Jump to search

September 2016arrow

Funding moves UC Davis scholars' research closer to the patient bedside

September 27, 2016

Preventing skin scarring with red light-emitting diodes and using small molecules in the breath to detect infections are just two of several innovative projects developed at UC Davis Health System that are moving closer to becoming new treatments and tools for improving patient care, thanks to the mentored research programs of the UC Davis Clinical and Translational Science Center (CTSC) and the Emergency Medicine K12 program. 

UC Davis joins large-scale effort to identify environmental influences on child health

September 26, 2016

UC Davis will receive $3.9 million from the National Institutes of Health to join the first phase of a seven-year initiative called Environmental influences on Child Health Outcomes, or ECHO.

Lam obtains major federal grants

September 23, 2016

Kit Lam, professor and chair of the UC Davis Department of Biochemistry and Molecular Medicine, has received two major cancer research grants totaling more than $3 million.

Gut pathogens thrive on body's tissue-repair mechanism

September 16, 2016

Why do some foodborne bacteria make us sick? A paper published Sept. 16 in the journal Science has found that pathogens in the intestinal tract cause harm because they benefit from immune system responses designed to repair the very damage to the intestinal lining caused by the bacteria in the first place.

Essential mouse genes could guide human precision medicine

September 14, 2016

About one-third of 1,751 genes studied in the first comprehensive survey of the mouse genome are essential to life, according to research by an international collaboration including the University of California, Davis, Mouse Biology Program. Mutations of these genes cause death at the embryo stage. Many of them have counterparts in the human genome, so understanding why these genes are so vital could help prioritize human genes for study.

NIH renews knockout mouse project

September 12, 2016

The University of California, Davis, has been awarded $29,290,259 from the National Institutes of Health under the next five-year phase of the Knockout Mouse Project. UC Davis is the lead organization in a consortium involving research partners at The Center for Phenogenomics in Toronto, Canada, the Childrens’ Hospital Oakland Research Institute and Charles River Laboratories in Wilmington, Mass.

Voices of patients and oncologists must be heard, study shows

September 9, 2016

Training oncologists and their patients to have high-quality discussions improves communication, but troubling gaps still exist between the two groups, according to a new study in JAMA Oncology.

Cognitive function tests reliable for people with intellectual disabilities, UC Davis research shows

September 6, 2016

Researchers at the UC Davis MIND Institute have found that a battery of tests appears to have strong potential for measuring cognitive changes over time for people with intellectual disabilities. The work could open new doors to research into whether drugs and specialized educational programs or treatments can improve function in people with Down syndrome, fragile X syndrome and other causes of intellectual disabilities.

UC Davis K12 scholars funded for cancer research

September 6, 2016

The National Cancer Institute has again funded the K12 Paul Calabresi Clinical Oncology Training Grant to promote and sustain the development of young cancer scientists from diverse fields and from laboratories and clinics across both UC Davis campuses.

August 2016arrow

IPHI report shows impact of cancer screening in California over past 15 years

August 31, 2016

A new report from the UC Davis Institute for Population Health Improvement (IPHI) shows the impact of cancer screening over the past 15 years, identifying areas where increased screening and other cancer-control efforts would save lives and significantly benefit population health.

Sertraline, brand named Zoloft, improves functioning in young children with fragile X

August 26, 2016

Treatment with sertraline may provide nominal but important improvements in cognition and social participation in very young children with fragile X syndrome, the most common genetic cause of intellectual disability and the leading single-gene cause of autism, a study by researchers with the UC Davis MIND Institute has found.

Lay educators help boost colorectal screening rates in Hmong

August 26, 2016

Hmong Americans are more likely to understand the importance of colorectal cancer screening and to get screened when they’re provided information by specially trained Hmong lay health educators, new research from UC Davis has found.

Specialized test detects bacterial infections in youngest infants with fever

August 23, 2016

Physicians from Children’s Hospital of Michigan, UC Davis Medical Center and Nationwide Children's Hospital, in collaboration with 19 other pediatric emergency departments around the country, have established a “proof of principle” for measuring patterns of ribonucleic acid (RNA) expression in the bloodstream that can enable clinicians to distinguish bacterial infections from other causes of fever in infants up to two months old.

Greenhalgh to lead study of burn shock treatment

August 12, 2016

The U.S. Department of Defense has awarded $2 million to David Greenhalgh, a UC Davis surgeon and national leader in treating burn injuries, for a study of the outcomes of a fluid resuscitation treatment for burn patients.

Study finds Hispanic men in California need more screening for colorectal cancer

August 11, 2016

Colorectal cancer incidence and mortality rates in California have decreased markedly for men and women in all major racial-ethnic groups since 1990, except for Hispanic men. Colorectal cancer rates for Hispanic men have remained relatively the same, a disparity that can be improved by greater screening, a study of colorectal cancer trends from the UC Davis Institute for Population Health Improvement (IPHI) finds. 

New grants help move innovative ideas to new discoveries

August 10, 2016

Two physician scientists received seed funding from the UC Davis Office of Research’s Science Translation and Innovative Research (STAIR) program to help them demonstrate proof-of-concept and commercial feasibility of their innovative technologies, which aim to address unmet market needs.

UC Davis scientists awarded $1 million grant for prostate cancer research

August 5, 2016

The Prostate Cancer Foundation and Movember, the global charity that has raised hundreds of millions for men’s health research and programs, have delivered $1 million to UC Davis prostate cancer researchers.

Alzheimer's Association issues $7 million challenge to scientists to speed drug discovery

August 2, 2016

Four cutting-edge studies, including one led by John Olichney, professor and neurologist at the UC Davis Alzheimer’s Disease Center, will each receive $1 million to advance current Alzheimer's research to the next stage of clinical trials. A unique, goal-driven competition offers an additional $3 million to the clinical trial that demonstrates the most promise for treating this devastating disease.

July 2016arrow

Hybrid treatment hunts down and kills leukemia cells

July 28, 2016

Researchers at UC Davis and Ionis Pharmaceuticals have developed a hybrid treatment that harnesses a monoclonal antibody to deliver antisense DNA to acute lymphoblastic leukemia (ALL) cells and that may lead to less toxic treatments for the disease.

2016-2017 MIND Institute Distinguished Lecturer Series starts Sept. 14

July 27, 2016

The UC Davis MIND Institute kicks off its 2016-2017 Distinguished Lecturer Series in September with an address by Robert H. Ring, associate professor at Drexel University in the College of Medicine, Department of Pharmacology and Physiology.

De Vere White to serve on prestigious NIH panel

July 26, 2016

Ralph de Vere White, who retired in June as director of the UC Davis Comprehensive Cancer Center, has been named to a key committee at the National Institute of Health (NIH).

UC Davis scientists awarded grant for rare genetic disorder research

July 21, 2016

The state stem cell agency, the California Institute for Regenerative Medicine (CIRM), today approved a $1.1 million grant to UC Davis for research aimed at developing a treatment for Angelman syndrome,  a rare, neurogenetic autism-spectrum disorder that occurs in one in 15,000 live births.

UC Davis researchers temporarily turn off brain area to better understand function

July 20, 2016

Capitalizing on experimental genetic techniques, researchers at UC Davis’ California National Primate Research Center (CNPRC) have demonstrated that temporarily turning off an area of the brain changes patterns of activity across much of the remaining brain.

High quality MRIs without sedation are possible in severely affected children with autism

July 19, 2016

UC Davis researchers have found a way to get MRI images of children with autism spectrum disorder (ASD) and intellectual disability without sedating them first using the principles of applied behavior analysis.

Historic data to aid in long-term study of ethnic disparities in brain health and dementia

July 14, 2016

Physical exams conducted from the 1960s through the 1980s will be revisited to evaluate risks and protective factors in early and midlife that could affect brain health and dementia diagnoses among a large, ethnically diverse group of seniors. The Kaiser Permanente Northern California Division of Research will partner with the UC Davis Alzheimer’s Disease Center for the study, which is funded with a five-year, $13 million grant from the National Institute on Aging.

Oncologists and cancer patients often differ in prognosis perceptions

July 14, 2016

Patients with stage III or IV cancer report far more optimistic expectations for survival than their oncologists thought they had communicated, according to new research published today in JAMA Oncology. Effective communication between doctors and their patients who could be nearing the end of their lives is crucial, according to the authors, since this is when quality-of-life decisions merge with discussions about treatment options.

New grant further solidifies UC Davis' leadership role in translational research

July 12, 2016

The UC Davis Clinical and Translational Science Center (CTSC) and the wide array of services that have supported innovative biomedical research and led to the development of new treatments for diseases during the past 10 years will continue, thanks to a $27.8 million grant from the National Center for Accelerating Translational Science and the ongoing support from the School of Medicine.

UC Davis scientists awarded grant for rare genetic disorder research

July 5, 2016

The London-based LouLou Foundation, in partnership with the Orphan Disease Center of the Perelman School of Medicine at the University of Pennsylvania, has awarded a grant to UC Davis Institute for Regenerative Cures Director Jan Nolta and one of the institute’s post-doctoral fellows, Kyle Fink, to study how Fink’s gene editing techniques might be used to treat a rare genetic disorder that hits children – mainly girls – at a very young age with difficult-to-control seizures and severe neuro-developmental impairment.